Viela Bio Appoints Mitchell Chan as Chief Financial Officer
July 01, 2019 at 07:00 am
Viela Bio announced the appointment of Mitchell Chan as Chief Financial Officer, effective July 1, 2019. In this role, he will be responsible for leading corporate financing, financial operations, treasury, investor relations, corporate communications and corporate strategy. Previously, Mr. Chan served as Viela’s Vice President, Head of Finance & Corporate Strategy. Mr. Chan has more than 15 years of finance experience. Prior to joining Viela in 2018, he served as Director of Investor Relations for AstraZeneca, North America.